PCOS Patient-Focused Drug Development Meeting (PCOS-PFDD) Samuel Riggs IV Alumni Center, College Park

Meeting Overview

PCOS affects up to 15% of women and can lead to severe health issues, yet lacks FDA-approved treatments. The PCOS EL-PFDD Meeting is a pivotal listening session for the FDA and industry stakeholders to learn from patients about their needs and priorities for new treatments.

Benefits for Patients Attending

– Directly inform the FDA and industry about the daily challenges and health effects of PCOS.

– Share perspectives on current treatment effectiveness.

– Highlight unmet needs and priorities for new treatments.

Benefits for Pharma/Industry Representatives Attending

– Gain an in-depth understanding of patients’ experiences and symptom burden.

– Learn factors influencing treatment choices and clinical trial participation.

– Drive more effective drug development by identifying unmet needs in PCOS care.

Admission: Free

For more information and to register, visit the PCOS PFDD Website.